Wire Stories
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies
PLEASANTON, Calif. & NANJING, China & SHANGHAI–(BUSINESS WIRE)–#BioPharmaceutical–IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative...